• Home »
  • Atlases and Data »
  • BICAN Rapid Release Inventory: Single cell transcriptomics and epigenomics
image representing the current explore topic

BICAN Rapid Release Inventory: Single cell transcriptomics and epigenomics

About the Rapid Release Inventory

October 1, 2024 release

The first public release of post-QC data from across the BRAIN Initiative Cell Atlas Network (BICAN) is now available in the Data Catalog.

It features data from 6 labs, totaling 255 donors, 1461 specimens(library aliquots), and 20 data collections. This includes developmental mouse data from the Allen Institute for Brain Science (Zeng) & University of California, San Francisco (Nowakowski), cross-species data from the Allen Institute for Brain Science (Lein) & marmoset data from Princeton University (Krienen), as well as multi-modal human data from Broad Institute (McCarroll) & Salk Institute for Biological Studies (Ecker).

It further establishes crucial infrastructure that integrates the Data Catalog with the Neuroanatomy-anchored Information Management Platform for Collaborative BICAN Data Generation (NIMP) and the fastq file storage at NeMO archive.

Access Rapid Release specimens Access the Rapid Release project Learn more about BICAN Rapid Release

 

About BICAN

The BRAIN Initiative® Cell Atlas Network (BICAN) is a collaborative effort uniting neuroscientists, computational biologists, and software engineers, to create a comprehensive atlas of the human brain. Supported by the U.S. BRAIN Initiative, BICAN awardees are dedicated to transforming our understanding of the brain by gathering and sharing new data that allows us to discover the basic components of the brain, detailing the vast array of neurons and non-neuronal cells across multiple species in adult and in development with an emphasis on how this informs our understanding of the human brain. A core mission of BICAN is to share data, knowledge, and tools with the neuroscience community, including single cell transcriptomics and epigenomics data, spatial transcriptomic assays, and multimodal interrogation of cell type morphology, electrophysiology, and transcriptomic phenotype.